Potential new pharmacological agents derived from medicinal plants for the treatment of pancreatic cancer

Pancreas

Volumn 44, Issue 1, 2015, Pages 11-15

  Azimi, Haniye ^a   Khakshur, Ali Asghar ^a   Abdollahi, Mohammad ^a   Rahimi, Roja ^b  

^a Faculty of Pharmacy Department of Pharmacology and Toxicology Pharmaceutical Sciences Research Center   (United States)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Medicinal plants; Pancreas; Pancreatic cancer; Pharmacological mechanisms; Phytochemical compounds; Systematic review

Indexed keywords

ALOE ARBORESCENS EXTRACT; ANTINEOPLASTIC AGENT; APIGENIN; BENZYL ISOTHIOCYANATE; CHELIDONIUM EXTRACT; CUCURBITACIN; CUCURBITACIN B; CURCUMA LONGA EXTRACT; CURCUMIN; DIHYDROARTEMISININ; EPIGALLOCATECHIN GALLATE; GARLIC EXTRACT; GENISTEIN; GINKGO BILOBA EXTRACT; ISOFLAVONE DERIVATIVE; NAPHTHOQUINONE; PERILLYL ALCOHOL; PHY 906; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; QUERCETIN; RESVERATROL; SULFORAPHANE; THYMOQUINONE; TOXICODENDRON VERNICIFLUUM EXTRACT; UNCLASSIFIED DRUG; VISCUM ALBUM EXTRACT; ANGIOGENESIS INHIBITOR; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; RADIOSENSITIZING AGENT;

ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; AUTOPHAGY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL CYCLE ARREST; CYTOTOXICITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MEDICINAL PLANT; MEDLINE; PANCREAS CANCER; REVIEW; TREATMENT OUTCOME; TUMOR REGRESSION; TUMOR VOLUME; ANIMAL; METABOLISM; PANCREATIC NEOPLASMS; PATHOLOGY; PHYTOTHERAPY;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; HUMANS; PANCREATIC NEOPLASMS; PHYTOTHERAPY; PLANTS, MEDICINAL; RADIATION-SENSITIZING AGENTS;

EID: 84919460412     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000175     Document Type: Review

References (211)

1. Michaud DS. Epidemiology of pancreatic cancer. Minerva Chir. 2004;59:99-111.
2. Li J, Saif MW. Advancements in the management of pancreatic cancer. JOP. 2009;10:109-117.
3. Dunphy EP. Pancreatic cancer: a review and update. Clin J Oncol Nurs. 2008;12:735-741.
4. Lakatos G, Tulassay Z. The epidemiology of pancreatic cancer. Orv Hetil. 2010;151:1816-1822.
5. Lowenfels AB, Maisonneuve P. Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol. 2006;20:197-209.
6. Saif MW. Pancreatic neoplasm in 2011: an update. JOP. 2011;12:316-321.
7. Koido S, Homma S, Takahara A, et al. Current immunotherapeutic approaches in pancreatic cancer. Clin Dev Immunol. 2011;2011:267539.
8. Conroy T, Gavoille C, Samalin E, et al. The role of the FOLFIRINOX regimen for advanced pancreatic cancer. Curr Oncol Rep. 2013;15:182-189.
9. Melstrom LG, Salabat MR, Ding XZ, et al. Apigenin down-regulates the hypoxia response genes: HIF-1?, GLUT-1, and VEGF in human pancreatic cancer cells. J Surg Res. 2011;167:173-181.
10. He L, Wu Y, Lin L, et al. Hispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2-mediated PI3K/Akt/mTOR signaling pathway. Cancer Sci. 2011;102:219-225.
11. Boreddy SR, Sahu RP, Srivastava SK. Benzyl isothiocyanate suppresses pancreatic tumor angiogenesis and invasion by inhibiting HIF-?/VEGF/Rho-GTPases: pivotal role of STAT-3. PLoS One. 2011;6:e25799.
12. Kuete V, Krusche B, Youns M, et al. Cytotoxicity of some Cameroonian spices and selected medicinal plant extracts. J Ethnopharmacol. 2011;134:803-812.
13. Kuete V, Wabo HK, Eyong KO, et al. Anticancer activities of six selected natural compounds of some Cameroonian medicinal plants. PLoS One. 2011;6:e21762.
14. Büchler P, Reber HA, Büchler MW, et al. Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia-inducible factor-1 and the down-regulation of VEGF gene expression. Cancer. 2004;100:201-210.
15. Kallifatidis G, Rausch V, Baumann B, et al. Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut. 2009;58:949-963.
16. Subramaniam D, Ramalingam S, Linehan DC, et al. RNA binding protein CUGBP2/CELF2 mediates curcumin-induced mitotic catastrophe of pancreatic cancer cells. PLoS One. 2011;6:e16958.
17. Zhou W, Kallifatidis G, Baumann B, et al. Dietary polyphenol quercetin targets pancreatic cancer stem cells. Int J Oncol. 2010;37:551-561.
18. Naumann P, Fortunato F, Zentgraf H, et al. Autophagy and cell death signaling following dietary sulforaphane act independently of each other and require oxidative stress in pancreatic cancer. Int J Oncol. 2011;39:101-109.
19. Mujumdar N, Mackenzie TN, Dudeja V, et al. Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways. Gastroenterology. 2010;139:598-608.
20. Ujiki MB, Ding XZ, Salabat MR, et al. Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest. Mol Cancer. 2006;5:76.
21. King JC, Lu QY, Li G, et al. Evidence for activation of mutated p53 by apigenin in human pancreatic cancer. Biochim Biophys Acta. 2012;1823:593-604.
22. Chen H, Sun B, Wang S, et al. Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-kappaB. J Cancer Res Clin Oncol. 2010;136:897-903.
23. Sahu RP, Zhang R, Batra S, et al. Benzyl isothiocyanate-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of MAPK in human pancreatic cancercells. Carcinogenesis. 2009;30:1744-1753.
24. Zhang R, Loganathan S, Humphreys I, et al. Benzyl isothiocyanate-induced DNA damage causes G2/M cell cycle arrest and apoptosis in human pancreatic cancer cells. J Nutr. 2006;136:2728-2734.
25. Sahu RP, Batra S, Srivastava SK. Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells. Br J Cancer. 2009;100:1425-1433.
26. Sun C, Zhang M, Shan X, et al. Inhibitory effect of cucurbitacin E on pancreatic cancer cells growth via STAT3 signaling. J Cancer Res Clin Oncol. 2010;136:603-610.
27. Zhang M, Sun C, Shan X, et al. Inhibition of pancreatic cancer cell growth by cucurbitacin B through modulation of signal transducer and activator of transcription 3 signaling. Pancreas. 2010;39:923-929.
28. Wiseman DA, Werner SR, Crowell PL. Cell cycle arrest by the isoprenoids perillyl alcohol, geraniol, and farnesol is mediated by p21(Cip1) and p27(Kip1)in human pancreatic adenocarcinoma cells. J Pharmacol Exp Ther. 2007;320:1163-1170.
29. Bao Y, Yuan Y, Xia L, et al. Neutral lipid isolated from endosperm of Job's tears inhibits the growth of pancreatic cancer cells via apoptosis, G2/M arrest, and regulation of gene expression. J Gastroenterol Hepatol. 2005;20:1046-1053.
30. Roy SK, Srivastava RK, Shankar S. Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and poptosis in pancreatic cancer. J Mol Signal. 2010;5:10.
31. Pham NA, Jacobberger JW, Schimmer AD, et al. The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficient mice. Mol Cancer Ther. 2004t;3:1239-1248.
32. Nair V, Dai Z, Khan M, et al. Pomegranate extract induces cell cycle arrest and alters cellular phenotype of human pancreatic cancer cells. Anticancer Res. 2011;31:2699-2704.
33. Okada T, Sawada T, Osawa T, et al. MK615 inhibits pancreatic cancer cell growth by dual inhibition of Aurora A and B kinases. World J Gastroenterol. 2008;14:1378-1382.
34. Rifai Y, Arai MA, Koyano T, et al. Terpenoids and a flavonoid glycoside from Acacia pennata leaves as hedgehog/GLI-mediated transcriptional inhibitors. J Nat Prod. 2010;73:995-997.
35. Rifai Y, Arai MA, Sadhu SK, et al. New Hedgehog/GLI signaling inhibitors from Excoecaria agallocha. Bioorg Med Chem Lett. 2011;21:718-722.
36. Arai MA, Tateno C, Koyano T, et al. New hedgehog/GLI-signaling inhibitors from Adenium obesum. Org Biomol Chem. 2011;9:1133-1139.
37. Arai MA, Tateno C, Hosoya T, et al. Hedgehog/GLI-mediated transcriptional inhibitors from Zizyphus cambodiana. Bioorg Med Chem. 2008;16:9420-9424.
38. George S, Bhalerao SV, Lidstone EA, et al. Cytotoxicity screening of Bangladeshi medicinal plant extracts on pancreatic cancer cells. BMC Complement Altern Med. 2010;10:52.
39. Chan LL, George S, Ahmad I, et al. Cytotoxicity effects of Amoora rohituka and chittagonga on breast and pancreatic cancer cells. Evid Based Complement Alternat Med. 2011;2011:860605.
40. Kim GS, Zeng L, Alali F, et al. Muricoreacin and murihexocin C, mono-tetrahydrofuran acetogenins, from the leaves of Annona muricata. Phytochemistry. 1998;49:565-571.
41. Awale S, Nakashima EM, Kalauni SK, et al. Angelmarin, a novel anti-cancer agent able to eliminate the tolerance of cancer cells to nutrient starvation. Bioorg Med Chem Lett. 2006;16:581-583.
42. Liu XX, Alali FQ, Pilarinou E, et al. Two bioactive mono-tetrahydrofuran acetogenins, annoglacins A and B, from Annona glabra. Phytochemistry. 1999;50:815-821.
43. Hopp DC, Zeng L, Gu ZM, et al. Novel mono-tetrahydrofuran ring acetogenins, from the bark of Annona squamosa, showing cytotoxic selectivities for the human pancreatic carcinoma cell line, PACA-2. J Nat Prod. 1997;60:581-586.
44. Awale S, Lu J, Kalauni SK, et al. Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation. Cancer Res. 2006;66:1751-1757.
45. Drag M, Surowiak P, Drag-Zalesinska M, et al. Comparison of the cytotoxic effects of birch bark extract, betulin and betulinic acid towards human gastric carcinoma and pancreatic carcinoma drug-sensitive and drug-resistant cell lines. Molecules. 2009;14:1639-1651.
46. Otsuki N, Dang NH, Kumagai E, et al. Aqueous extract of Carica papaya leaves exhibits anti-tumor activity and immunomodulatory effects. J Ethnopharmacol. 2010;127:1760-1767.
47. Win NN, Awale S, Esumi H, et al. Novel anticancer agents, kayeassamins A and B from the flower of Kayea assamica of Myanmar. Bioorg Med Chem Lett. 2008;18:4688-4691.
48. Win NN, Awale S, Esumi H, et al. Novel anticancer agents, kayeassamins C-I from the flower of Kayea assamica of Myanmar. Bioorg Med Chem. 2008;16:8653-8660.
49. Win NN, Awale S, Esumi H, et al. Panduratins D-I, novel secondary metabolites from rhizomes of Boesenbergia pandurata. Chem Pharm Bull (Tokyo). 2008;56:491-496.
50. Win NN, Awale S, Esumi H, et al. Bioactive secondary metabolites from Boesenbergia pandurata of Myanmar and their preferential cytotoxicity against human pancreatic cancer PANC-1 cell line in nutrient-deprived medium. J Nat Prod. 2007;70:1582-1587.
51. Zhao M, Lau ST, Leung PS, et al. Seven quassinoids from Fructus bruceae with cytotoxic effects on pancreatic adenocarcinoma cell lines. Phytother Res. 2011;25:1796-1800.
52. Swaffar DS, Ang CY, Desai PB, et al. Combination therapy with 5-fluorouracil and L-canavanine: in vitro and in vivo studies. Anticancer Drugs. 1995;6:586-593.
53. Ye CL, Liu Y, Wei DZ. Antioxidant and anticancer activity of 3'-formyl-4', 6'-dihydroxy-2'-methoxy-5'-methylchalcone and (2S)-8-formyl-5-hydroxy-7-methoxy-6-methylflavanone. J Pharm Pharmacol. 2007;59:553-559.
54. Rogers LL, Zeng L, Kozlowski JF, et al. New bioactive triterpenoids from Melia volkensii. J Nat Prod. 1998;61:64-70.
55. Rooney S, Ryan MF. Effects of alpha-hederin and thymoquinone, constituents of Nigella sativa, on human cancer cell lines. Anticancer Res. 2005;25:2199-2204.
56. Rifai Y, Arai MA, Koyano T, et al. 2'-acetate: a Hedgehog signaling inhibitory constituent from Vallaris glabra. J Nat Med. 2011;65:629-632.
57. Awale S, Linn TZ, Li F, et al. Identification of chrysoplenetin from Vitex negundo as a potential cytotoxic agent against PANC-1 and a panel of 39 human cancer cell lines (JFCR-39). Phytother Res. 2011;25:1770-1775.
58. Li Y, Vandenboom TG II, Wang Z, et al. miR-146a suppresses invasion of pancreatic cancer cells. Cancer Res. 2010;70:1486-1495.
59. Tang SN, Fu J, Nall D, et al. Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics. Int J Cancer 2012;131:30-40.
60. Srivastava RK, Tang SN, Zhu W, et al. Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells. Front Biosci (Elite Ed). 2011;3:515-528.
61. Shankar S, Ganapathy S, Hingorani SR, et al. EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front Biosci. 2008;13:440-452.
62. Ali S, Ahmad A, Banerjee S, et al. Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. Cancer Res. 2010;70:3606-3617.
63. Sun M, Estrov Z, Ji Y, et al. Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol Cancer Ther. 2008;7:464-473.
64. Liu A, Chen H, Wei W, et al. Antiproliferative and antimetastatic effects of emodin on human pancreatic cancer. Oncol Rep. 2011;26:81-89.
65. Liu A, Sha L, Shen Y, et al. Experimental study on anti-metastasis effect of emodin on human pancreatic cancer. Zhongguo Zhong Yao Za Zhi. 2011;36:3167-3171.
66. Huang YT, Lee LT, Lee PP, et al. Targeting of focal adhesion kinase by flavonoids and small-interfering RNAs reduces tumor cell migration ability. Anticancer Res. 2005;25:2017-2025.
67. Bao B, Wang Z, Ali S, et al. Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells. J Cell Biochem. 2011;112:2296-2306.
68. Bao B, Wang Z, Ali S, et al. Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Lett. 2011;307:26-36.
69. Wang Z, Zhang Y, Li Y, et al. Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Mol Cancer Ther. 2006;5:483-493.
70. Su FQ, Li HY, Zhang Y, et al. Effect of icogenin on and its mechanism in anti-metastasis of pancreatic cancer BxPC3 cells. Yao Xue Xue Bao. 2009;44:456-461.
71. Wu ZH, Chen Z, Shen Y, et al. Anti-metastasis effect of thymoquinone on human pancreatic cancer. Yao Xue Xue Bao. 2011;46:910-914.
72. Torres MP, Ponnusamy MP, Chakraborty S, et al. Effects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: implications for the development of novel cancer therapies. Mol Cancer Ther. 2010;9:1419-1431.
73. Shinkai K, Akedo H, Mukai M, et al. Inhibition of in vitro tumor cell invasion by ginsenoside Rg3. Jpn J Cancer Res. 1996;87:357-362.
74. Mouria M, Gukovskaya AS, Jung Y, et al. Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis. Int J Cancer. 2002;98:761-769.
75. Shankar S, Nall D, Tang SN, et al. Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. PLoS One. 2011;6:e16530.
76. Chua AW, Hay HS, Rajendran P, et al. Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-?B activation in breast and pancreatic tumor cells. Biochem Pharmacol. 2010;80:1553-1562.
77. Hoffmann J, Junker H, Schmieder A, et al. EGCG downregulates IL-1RI expression and suppresses IL-1-induced tumorigenic factors in human pancreatic adenocarcinoma cells. Biochem Pharmacol. 2011;82:1153-1162.
78. Kürbitz C, Heise D, Redmer T, et al. Epicatechin gallate and catechin gallate are superior to epigallocatechin gallate in growth suppression and anti-inflammatory activities in pancreatic tumor cells. Cancer Sci. 2011;102:728-734.
79. Barrajón-Catalán E, Fernández-Arroyo S, Saura D, et al. Cistaceae aqueous extracts containing ellagitannins show antioxidant and antimicrobial capacity, and cytotoxic activity against human cancer cells. Food Chem Toxicol. 2010;48:2273-2282.
80. Chehl N, Chipitsyna G, Gong Q, et al. Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells. HPB (Oxford). 2009;11:373-381.
81. Subbarayan PR, Sarkar M, Impellizzeri S, et al. Anti-proliferative and anti-cancer properties of Achyranthes aspera: specific inhibitory activity against pancreatic cancer cells. J Ethnopharmacol. 2010;131:78-82.
82. Seki T, Kokuryo T, Yokoyama Y, et al. Antitumor effects of ?-bisabolol against pancreatic cancer. Cancer Sci. 2011;102:2199-2205.
83. Salabat MR, Melstrom LG, Strouch MJ, et al. Geminin is overexpressed in human pancreatic cancer and downregulated by the bioflavanoid apigenin in pancreatic cancer cell lines. Mol Carcinog. 2008;47:835-844.
84. Chen LP, Zhao F, Wang Y, et al. Antitumor effect of resorcinol derivatives from the roots of Ardisia brevicaulis by inducing apoptosis. J Asian Nat Prod Res. 2011;13:734-743.
85. Noori S, Hassan ZM. Dihydroartemisinin shift the immune response towards Th1, inhibit the tumor growth in vitro and in vivo. Cell Immunol. 2011;271:67-72.
86. Lyn-Cook BD, Stottman HL, Yan Y, et al. The effects of phytoestrogens on human pancreatic tumor cells in vitro. Cancer Lett. 1999;142:111-119.
87. Vu HA, Beppu Y, Chi HT, et al. Green tea epigallocatechin gallate exhibits anticancer effect in human pancreatic carcinoma cells via the inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor. J Biomed Biotechnol. 2010;2010:290516.
88. Li Y, Zhang T, Jiang Y, et al. (?)-Epigallocatechin-3-gallate inhibits Hsp90 function by impairing Hsp90 association with cochaperones in pancreatic cancer cell line Mia Paca-2. Mol Pharm. 2009;6:1152-1159.
89. Swaffar DS, Ang CY, Desai PB, et al. Inhibition of the growth of human pancreatic cancer cells by the arginine antimetabolite L-canavanine. Cancer Res. 1994;54:6045-6048.
90. Johnson JL, Rupasinghe SG, Stefani F, et al. Citrus flavonoids luteolin, apigenin, and quercetin inhibit glycogen synthase kinase-3? enzymatic activity by lowering the interaction energy within the binding cavity. J Med Food. 2011;14:325-333.
91. Basu A, Alder H, Khiyami A, et al. MicroRNA-375 andMicroRNA-221: potential noncoding RNAs associated with antiproliferative activity of benzyl isothiocyanate in pancreatic cancer. Genes Cancer. 2011;2:108-119.
92. Srivastava SK, Singh SV. Cell cycle arrest, apoptosis induction and inhibition of nuclear factor kappa B activation in anti-proliferative activity of benzyl isothiocyanate against human pancreatic cancer cells. Carcinogenesis. 2004;25:1701-1709.
93. Li Y, Zhang T, Schwartz SJ, et al. Sulforaphane potentiates the efficacy of 17-allylamino 17-demethoxygeldanamycin against pancreatic cancer through enhanced abrogation of Hsp90 chaperone function. Nutr Cancer. 2011;63:1151-1159.
94. Glienke W, Maute L, Wicht J, et al. Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells. Eur J Cancer. 2009;45:874-880.
95. Jutooru I, Chadalapaka G, Lei P, et al. Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation. J Biol Chem. 2010;285:25332-25344.
96. Aggarwal S, Ndinguri MW, Solipuram R, et al. DLys(6)-luteinizing hormone releasing hormone-curcumin conjugate inhibits pancreatic cancer cell growth in vitro and in vivo. Int J Cancer. 2011;129:1611-1623.
97. Chicca A, Pellati F, Adinolfi B, et al. Cytotoxic activity of polyacetylenes and polyenes isolated from roots of Echinacea pallida. Br J Pharmacol. 2008;153:879-885.
98. Duarte N, Lage H, Abrantes M, et al. Phenolic compounds as selective antineoplasic agents against multidrug-resistant human cancer cells. Planta Med. 2010;76:975-980.
99. Lian JP, Word B, Taylor S, et al. Modulation of the constitutive activated STAT3 transcription factor in pancreatic cancer prevention: effects of indole-3-carbinol (I3C) and genistein. Anticancer Res. 2004;24:133-137.
100. Boros LG, Bassilian S, Lim S, et al. Genistein inhibits nonoxidative ribose synthesis in MIA pancreatic adenocarcinoma cells: a new mechanism of controlling tumor growth. Pancreas. 2001;22:1-7.
101. Mimaki Y, Sashida Y, Kuroda M, et al. Inhibitory effects of steroidal saponins on 12-O-tetradecanoylphorbol-13-acetate (TPA)-enhanced 32P-incorporation into phospholipids of HeLa cells and proliferation of human malignant tumor cells. Biol Pharm Bull. 1995;18:467-469.
102. Karlson J, Borg-Karlson AK, Unelius R, et al. Inhibition of tumor cell growth by monoterpenes in vitro: evidence of a Ras-independent mechanism of action. Anticancer Drugs. 1996;7:422-429.
103. Murtaza I, Saleem M, Adhami VM, et al. Suppression of cFLIP by lupeol, a dietary triterpene, is sufficient to overcome resistance to TRAIL-mediated apoptosis in chemoresistant human pancreatic cancer cells. Cancer Res. 2009;69:1156-1165.
104. Saleem M, Kaur S, Kweon MH, et al. Lupeol, a fruit and vegetable based triterpene, induces apoptotic death of human pancreatic adenocarcinoma cells via inhibition of Ras signaling pathway. Carcinogenesis. 2005;26:1956-1964.
105. Stayrook KR, McKinzie JH, Barbhaiya LH, et al. Effects of the antitumor agent perillyl alcohol on H-Ras vs K-Ras farnesylation and signal transduction in pancreatic cells. Anticancer Res. 1998;18:823-828.
106. Stark MJ, Burke YD, McKinzie JH, et al. Chemotherapy of pancreatic cancer with the monoterpene perillyl alcohol. Cancer Lett. 1995;96:15-21.
107. Hafeez BB, Jamal MS, Fischer JW, et al. Plumbagin, a plant derived natural agent inhibits the growth of pancreatic cancer cells in in vitro and in vivo via targeting EGFR, Stat3 and NF-?B signaling pathways. Int J Cancer. 2012;131:2175-2186.
108. Mo W, Xu X, Xu L, et al. Resveratrol inhibits proliferation and induces apoptosis through the hedgehog signaling pathway in pancreatic cancer cell. Pancreatology. 2012;11:601-609.
109. Roy SK, Chen Q, Fu J, et al. Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors. PLoS One. 2011;6:e25166.
110. Golkar L, Ding XZ, Ujiki MB, et al. Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1. J Surg Res. 2007;138:163-169.
111. Oi N, Jeong CH, Nadas J, et al. Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A4 hydrolase. Cancer Res. 2010;70:9755-9764.
112. Harikumar KB, Kunnumakkara AB, Sethi G, et al. Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer. Int J Cancer. 2010;127:257-268.
113. Mannal PW, Alosi JA, Schneider JG, et al. Pterostilbene inhibits pancreatic cancer in vitro. J Gastrointest Surg. 2010;14:873-879.
114. Cai J, Razzak A, Hering J, et al. Feasibility evaluation of emodin (rhubarb extract) as an inhibitor of pancreatic cancer cell proliferation in vitro. JPEN J Parenter Enteral Nutr. 2008;32:190-196.
115. Patil S, Narayanan S, Eibl G, et al. Evaluation of antimitotic activity of Rotula aquatica (Lour): a traditional herb used in treatment of cancer. Indian J Exp Biol. 2004;42:893-899.
116. Shabbeer S, Sobolewski M, Anchoori RK, et al. Fenugreek: a naturally occurring edible spice as an anticancer agent. Cancer Biol Ther. 2009;8:272-278.
117. Schwarz RE, Wojciechowicz DC, Picon AI, et al. Wheatgerm agglutinin-mediated toxicity in pancreatic cancer cells. Br J Cancer. 1999;80:1754-1762.
118. Sigurdsson S, Ogmundsdottir HM, Gudbjarnason S. Antiproliferative effect of Angelica archangelica fruits. Z Naturforsch C. 2004;59:523-527.
119. Liu T, Song Y, Chen H, et al. Matrine inhibits proliferation and induces apoptosis of pancreatic cancer cells in vitro and in vivo. Biol Pharm Bull. 2010;33:1740-1745.
120. Sheridan H, Nestor C, O'Driscoll L, et al. Isolation, structure elucidation, and cytotoxic evaluation of furanonaphthoquinones from in vitro plantlets and cultures of Streptocarpus dunnii. J Nat Prod. 2011;74:82-85.
121. Liu JW, Cai MX, Xin Y, et al. Parthenolide induces proliferation inhibition and apoptosis of pancreatic cancer cells in vitro. J Exp Clin Cancer Res. 2010;29:108.
122. Yip-Schneider MT, Nakshatri H, Sweeney CJ, et al. Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cells. Mol Cancer Ther. 2005;4:587-594.
123. Boros LG, Lapis K, Szende B, et al. Wheat germ extract decreases glucose uptake and RNA ribose formation but increases fatty acid synthesis in MIA pancreatic adenocarcinoma cells. Pancreas. 2001;23:141-147.
124. Hara A, Iizuka N, Hamamoto Y, et al.Molecular dissection of a medicinal herb with anti-tumor activity by oligonucleotide microarray. Life Sci. 2005;77:991-1002.
125. Lage H, Duarte N, Coburger C, et al. Antitumor activity of terpenoids against classical and atypical multidrug resistant cancer cells. Phytomedicine. 2010;17:441-448.
126. Duarte N, Lage H, Ferreira MJ. Three new jatrophane polyesters and antiproliferative constituents from Euphorbia tuckeyana. Planta Med. 2008;74:61-68.
127. Kuete V, Wiench B, Hegazy ME, et al. Antibacterial activity and cytotoxicity of selected Egyptian medicinal plants. Planta Med. 2012;78:193-199.
128. Lee LT, Huang YT, Hwang JJ, et al. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Anticancer Res. 2002;22:1615-1627.
129. Zhang Y, Chen AY, Li M, et al. Ginkgo biloba extract kaempferol inhibits cell proliferation and induces apoptosis in pancreatic cancer cells. J Surg Res. 2008;148:17-23.
130. Burke YD, Stark MJ, Roach SL, et al. Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol. Lipids. 1997;32:151-156.
131. Aung W, Sogawa C, Furukawa T, et al. Anticancer effect of dihydroartemisinin (DHA) in a pancreatic tumor model evaluated by conventional methods and optical imaging. Anticancer Res. 2011;31:1549-1558.
132. McMillan B, Riggs DR, Jackson BJ, et al. Dietary influence on pancreatic cancer growth by catechin and inositol hexaphosphate. J Surg Res. 2007;141:115-119.
133. Chidambara Murthy KN, Jayaprakasha GK, Patil BS. Apoptosis mediated cytotoxicity of citrus obacunone in human pancreatic cancer cells. Toxicol In Vitro. 2011;25:859-867.
134. Lau ST, Lin ZX, Liao Y, et al. Bruceine D induces apoptosis in pancreatic adenocarcinoma cell line PANC-1 through the activation of p38-mitogen activated protein kinase. Cancer Lett. 2009;281:42-52.
135. Shankar S, Suthakar G, Srivastava RK. Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer. Front Biosci. 2007;12:5039-5051.
136. Patil JR, Chidambara Murthy KN, Jayaprakasha GK, et al. Bioactive compounds from Mexican lime (Citrus aurantifolia) juice induce apoptosis in human pancreatic cells. J Agric Food Chem. 2009;57:10933-10942.
137. Boreddy SR, Pramanik KC, Srivastava SK. Pancreatic tumor suppression by benzyl isothiocyanate is associated with inhibition of PI3K/AKT/FOXO pathway. Clin Cancer Res. 2011;17:1784-1795.
138. Batra S, Sahu RP, Kandala PK, et al. Benzyl isothiocyanate-mediated inhibition of histone deacetylase leads to NF-kappaB turnoff in human pancreatic carcinoma cells. Mol Cancer Ther. 2010;9:1596-1608.
139. Basu A, Haldar S. Anti-proliferative and proapoptotic effects of benzyl isothiocyanate on human pancreatic cancer cells is linked to death receptor activation and RasGAP/Rac1 down-modulation. Int J Oncol. 2009;35:593-599.
140. Sahu RP, Srivastava SK. The role of STAT-3 in the induction of apoptosis in pancreatic cancer cells by benzyl isothiocyanate. J Natl Cancer Inst. 2009;101:176-193.
141. Basu A, Haldar S. Dietary isothiocyanate mediated apoptosis of human cancer cells is associated with Bcl-xL phosphorylation. Int J Oncol. 2008;33:657-663.
142. Wang Z, Zhang Y, Banerjee S, et al. Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer. 2006;106:2503-2513.
143. Stayrook KR, McKinzie JH, Burke YD, et al. Induction of the apoptosis-promoting protein Bak by perillyl alcohol in pancreatic ductal adenocarcinoma relative to untransformed ductal epithelial cells. Carcinogenesis. 1997;18:1655-1658.
144. Chen CA, Chang HH, Kao CY, et al. Plumbagin, isolated from Plumbago zeylanica, induces cell death through apoptosis in human pancreatic cancer cells. Pancreatology. 2009;9:797-809.
145. Lee SJ, Jung YS, Lee SH, et al. Isolation of a chemical inhibitor against K-Ras-induced p53 suppression through natural compound screening. Int J Oncol. 2009;34:1637-1643.
146. Zhou JH, Cheng HY, Yu ZQ, et al. Resveratrol induces apoptosis in pancreatic cancer cells. Chin Med J (Engl). 201;124:1695-1699.
147. Sun W, Wang W, Kim J, et al. Anti-cancer effect of resveratrol is associated with induction of apoptosis via a mitochondrial pathway alignment. Adv Exp Med Biol. 2008;614:179-186.
148. Kotha A, Sekharam M, Cilenti L, et al. Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein. Mol Cancer Ther. 2006;5:621-629.
149. Ahsan H, Reagan-Shaw S, Breur J, et al. Sanguinarine induces apoptosis of human pancreatic carcinoma AsPC-1 and BxPC-3 cells via modulations in Bcl-2 family proteins. Cancer Lett. 2007;249:198-208.
150. Takahashi H, Chen MC, Pham H, et al. Baicalein, a component of Scutellaria baicalensis, induces apoptosis by Mcl-1 down-regulation in human pancreatic cancer cells. Biochim Biophys Acta. 2011;1813:1465-1474.
151. Ling Q, Xu X, Wei X, et al. Oxymatrine induces human pancreatic cancer PANC-1 cells apoptosis via regulating expression of Bcl-2 and IAP families, and releasing of cytochrome c. J Exp Clin Cancer Res. 2011;30:66.
152. Thoennissen NH, Iwanski GB, Doan NB, et al. Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells. Cancer Res. 2009;69:5876-5884.
153. Zhou GX, Ding XL, Huang JF, et al. Apoptosis of human pancreatic cancer cells induced by Triptolide. World J Gastroenterol. 2008;14:1504-1509.
154. Wang X, Matta R, Shen G, et al. Mechanism of triptolide-induced apoptosis: Effect on caspase activation and Bid cleavage and essentiality of the hydroxyl group of triptolide. J Mol Med. 2006;84:405-415.
155. Phillips PA, Dudeja V, McCarroll JA, et al. Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70. Cancer Res. 2007;67:9407-9416.
156. Ding X, Zhou X, Zhang H, et al. Triptolide augments the effects of 5-lipoxygenase RNA interference in suppressing pancreatic tumor growth in a xenograft mouse model. Cancer Chemother Pharmacol. 2012;69:253-261.
157. Nozawa F, Itami A, Saruc M, et al. The combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) and Genistein is effective in inhibiting pancreatic cancer growth. Pancreas. 2004;29:45-52.
158. Jian J, Hu ZF, Huang Y. Effect of ginsenoside Rg3 on Pim-3 and Bad proteins in human pancreatic cancer cell line PANC-1. Ai Zheng. 2009;28:461-465.
159. Ea S, Giacometti S, Ciccolini J, et al. Cytotoxic effects of haplamine and its major metabolites on human cancer cell lines. Planta Med. 2008;74:1265-1268.
160. Strouch MJ, Milam BM, Melstrom LG, et al. The flavonoid apigenin potentiates the growth inhibitory effects of gemcitabine and abrogates gemcitabine resistance in human pancreatic cancer cells. Pancreas. 2009;38:409-415.
161. Lee SH, Ryu JK, Lee KY, et al. Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer. Cancer Lett. 2008;259:39-49.
162. Wang SJ, Gao Y, Chen H, et al. Dihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo. Cancer Lett. 2010;293:99-108.
163. Wang SJ, Sun B, Pan SH, et al. Experimental study of the function and mechanism combining dihydroartemisininand gemcitabine in treating pancreatic cancer. Zhonghua Wai Ke Za Zhi. 2010;48:530-534.
164. Veeraraghavan J, Natarajan M, Lagisetty P, et al. Impact of curcumin, raspberry extract, and neem leaf extract on rel protein-regulated cell death/radiosensitization in pancreatic cancer cells. Pancreas. 2011;40:1107-1119.
165. Basu A, Haldar S. Combinatorial effect of epigallocatechin-3-gallate and TRAIL on pancreatic cancer cell death. Int J Oncol. 2009;34:281-286.
166. Bence AK, Adams VR, Crooks PA. L-Canavanine as a radiosensitization agent for human pancreatic cancer cells. Mol Cell Biochem. 2003;244:37-43.
167. Ohara M, Kimura S, Tanaka A, et al. Benzyl isothiocyanate sensitizes human pancreatic cancer cells to radiation by inducing apoptosis. Int J Mol Med. 2011;28:1043-1047.
168. Sahu RP, Epperly MW, Srivastava SK. Benzyl isothiocyanate sensitizes human pancreatic cancer cells to radiation therapy. Front Biosci (Elite Ed). 2009;1:568-576.
169. Wicker CA, Sahu RP, Kulkarni-Datar K, et al. BITC sensitizes pancreatic adenocarcinomas to TRAIL-induced apoptosis. Cancer Growth Metastasis. 2010;2009:45-55.
170. Kallifatidis G, Labsch S, Rausch V, et al. Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate. Mol Ther. 2011;19:188-195.
171. Rausch V, Liu L, Kallifatidis G, et al. Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics. Cancer Res. 2010;70:5004-5013.
172. Wang ZH, Chen H, Guo HC, et al. Enhanced antitumor efficacy by the combination of emodin and gemcitabine against human pancreatic cancer cells via downregulation of the expression of XIAP in vitro and in vivo. Int J Oncol. 2011;39:1123-1131.
173. Liu DL, Bu H, Li H, et al. Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro. Int J Oncol. 2012;40:1049-1057.
174. Guo Q, Chen Y, Zhang B, et al. Potentiation of the effect of gemcitabine by emodin in pancreatic cancer is associated with surviving inhibition. Biochem Pharmacol. 2009;77:1674-1683.
175. Chen H, Wei W, Guo Y, et al. Enhanced effect of gemcitabine by emodin against pancreatic cancer in vivo via cytochrome C-regulated apoptosis. Oncol Rep. 2011;25:1253-1261.
176. Banerjee S, Kong D, Azmi AS, et al. Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cells in vitro and in vivo. Int J Cancer. 2011;128:1240-1250.
177. Banerjee S, Zhang Y, Wang Z, et al. In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer. Int J Cancer. 2007;120:906-917.
178. Banerjee S, Zhang Y, Ali S, et al. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. Cancer Res. 2005;65:9064-9072.
179. Mohammad RM, Banerjee S, Li Y, et al. Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts. Cancer. 2006;106:1260-1268.
180. Wang H, Word BR, Lyn-Cook BD. Enhanced efficacy of gemcitabine by indole-3-carbinol in pancreatic cell lines: the role of human equilibrative nucleoside transporter 1. Anticancer Res. 2011;31:3171-3180.
181. Banerjee S, Kaseb AO, Wang Z, et al. Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer. Cancer Res. 2009;69:5575-5583.
182. Borska S, Sopel M, Chmielewska M, et al. Quercetin as a potential modulator of P-glycoprotein expression and function in cells of human pancreatic carcinoma line resistant to daunorubicin. Molecules. 2010;15:857-870.
183. Fulda S, Debatin KM. Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer Res. 2004;64:337-346.
184. Yang SW, Wang W, Xie XY, et al. In vitro synergistic cytotoxic effect of triptolide combined with hydroxycamptothecin on pancreatic cancer cells. Am J Chin Med. 2011;39:121-134.
185. Borja-Cacho D, Yokoyama Y, Chugh RK, et al. TRAIL and triptolide: an effective combination that induces apoptosis in pancreatic cancer cells. J Gastrointest Surg. 2010;14:252-260.
186. Wang W, Yang S, Su Y, et al. Enhanced antitumor effect of combined triptolide and ionizing radiation. Clin Cancer Res. 2007;13:4891-4899.
187. Bisht S, Mizuma M, Feldmann G, et al. Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer. Mol Cancer Ther. 2010;9:2255-2264.
188. Ishikawa H, Saeki T, Otani T, et al. Aged garlic extract prevents a decline of NK cell number and activity in patients with advanced cancer. J Nutr. 2006;136:816S-820S.
189. Lissoni P, Rovelli F, Brivio F, et al. A randomized study of chemotherapy versus biochemotherapy with chemotherapy plus Aloe arborescens in patients with metastatic cancer. In Vivo. 2009;23:171-175.
190. Zemskov VS, Procopchuk OL, Susak YM, et al. Ukrain (NSC-631570) in the treatment of pancreas cancer. Drugs Exp Clin Res. 2000;26:179-190.
191. Zemskov V, Prokopchuk O, Susak Y, et al. Efficacy of ukrain in the treatment of pancreatic cancer. Langenbecks Arch Surg. 2002;387:84-89.
192. Gansauge F, Ramadani M, Pressmar J, et al. NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer. Results of a phase II trial. Langenbecks Arch Surg. 2002;386:570-574.
193. Dhillon N, Aggarwal BB, Newman RA, et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res. 2008;14:4491-4499.
194. Kanai M, Yoshimura K, Asada M, et al. A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemother Pharmacol. 2011;68:157-164.
195. Epelbaum R, Schaffer M, Vizel B, et al. Curcumin and gemcitabine in patients with advanced pancreatic cancer. Nutr Cancer. 2010;62:1137-1141.
196. Hauns B, Häring B, Köhler S, et al. Phase II study with 5-fluorouracil and ginkgo biloba extract (GBE 761 ONC) in patients with pancreatic cancer. Arzneimittelforschung. 1999;49:1030-1034.
197. Lee S, Kim K, Jung H, et al. Efficacy and safety of standardized allergen-removed Rhus verniciflua stokes extract in patients with advanced or metastatic pancreatic cancer: a Korean single-center experience. Oncology. 2011;81:312-318.
198. Friess H, Beger HG, Kunz J, et al. Treatment of advanced pancreatic cancer with mistletoe: results of a pilot trial. Anticancer Res. 1996;16:915-920.
199. Matthes H, Friedel WE, Bock PR, et al. Molecular mistletoe therapy: friend or foe in established anti-tumor protocols? A multicenter, controlled, retrospective pharmaco-epidemiological study in pancreas cancer. Curr Mol Med. 2010;10:430-439.
200. Enesel MB, Acalovschi I, Grosu V, et al. Perioperative application of the Viscum album extract Isorel in digestive tract cancer patients. Anticancer Res. 2005;25:4583-4590.
201. Matos JM, Schmidt CM, Thomas HJ, et al. A pilot study of perillyl alcohol in pancreatic cancer. J Surg Res. 2008;147:194-199.
202. Saif MW, Lansigan F, Ruta S, et al. Phase I study of the botanical formulation PHY906 with capecitabine in advanced pancreatic and other gastrointestinal malignancies. Phytomedicine. 2010;17:161-169.
203. El-Rayes BF, Philip PA, Sarkar FH, et al. A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer. Invest New Drugs. 2011;29:694-699.
204. Melstrom LG, Salabat MR, Ding XZ, et al. Apigenin inhibits the GLUT-1 glucose transporter and the phosphoinositide 3-kinase/Akt pathway in human pancreatic cancer cells. Pancreas. 2008;37:426-431.
205. Hutzen B, Willis W, Jones S, et al. Dietary agent, benzyl isothiocyanate inhibits signal transducer and activator of transcription 3 phosphorylation and collaborates with sulforaphane in the growth suppression of PANC-1 cancer cells. Cancer Cell Int. 2009;9:24.
206. Wang Z, Ahmad A, Banerjee S, et al. FoxM1 is a novel target of a natural agent in pancreatic cancer. Pharm Res. 2010;27:1159-1168.
207. Mohammad RM, Wang S, Banerjee S, et al. Nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-XL, (?)-Gossypol, enhances biological effect of genistein against BxPC-3 human pancreatic cancer cell line. Pancreas. 2005;31:317-324.
208. Somasundar P, Riggs DR, Jackson BJ, et al. Inositol hexaphosphate (IP6): a novel treatment for pancreatic cancer. J Surg Res. 2005;126:199-203.
209. Wang W, Adachi M, Zhang R, et al. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells. Pancreas. 2009;38:e114-e123.
210. Iwanski GB, Lee DH, En-Gal S, et al. Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer. Br J Pharmacol. 2010;160:998-1007.
211. Wei WT, Chen H, Ni ZL, et al. Antitumor and apoptosis-promoting properties of emodin, an anthraquinone derivative from Rheum officinale Baill, against pancreatic cancer in mice via inhibition of Akt activation. Int J Oncol. 2011;39:1381-1390.